Notably, glycosylated hemoglobin (Hb) in diabetes becomes a preferred target for vascular NO, producing tightly bounded NO [30], thereby likely reducing the overall delivery of bioactive NO in diabetic vasculature. The gene discussed is GSTM1; the disease is diabetes mellitus.